Overview

Special Drug Use-Results Survey of Lipitor Tablets

Status:
Completed
Trial end date:
2012-03-01
Target enrollment:
Participant gender:
Summary
This study is to evaluate the controlling effect of atrovastatin on plasma lipid to achieve the category-specific targeted lipid levels.
Details
Lead Sponsor:
Astellas Pharma Inc
Treatments:
Atorvastatin
Atorvastatin Calcium